# Comparative Study of Rosuvastatin/Ezetimib 20/10 mg and Atovastatin/Ezetimib 40/10 mg (TOLERANT Trial)

> **NCT05910476** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **Yonsei University** · enrollment: 200 (estimated)

## Conditions studied

- Coronary Artery Disease
- Dyslipidemias

## Interventions

- **DRUG:** a high dose of statin/ezetimib

## Key facts

- **NCT ID:** NCT05910476
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-05-03
- **Primary completion:** 2026-09-22
- **Final completion:** 2026-09-22
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2025-11-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05910476

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05910476, "Comparative Study of Rosuvastatin/Ezetimib 20/10 mg and Atovastatin/Ezetimib 40/10 mg (TOLERANT Trial)". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT05910476. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*